ask="0.7500"
ask_size="500"
average_daily_volume="2352330"
bid="0.6910"
bid_size="5000"
book_value="0.1800"
change="-0.0390"
change_from_200_day_moving_average="-1.2531"
change_from_50_day_moving_average="0.0743"
change_from_52_week_high="-4.2016"
change_From_52_week_low="0.1884"
change_in_percent="-5.2888%"
close="0.6984"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.6100"
ebitda="-56.86M"
eps_estimate_current_year="-1.2300"
eps_estimate_next_quarter="-0.2600"
eps_estimate_next_year="-1.0800"
ex_dividend_date="N/A"
float_shares="36794000"
high="0.7689"
high_52_weeks="4.9000"
last_trade_date="3/2/2017"
last_trade_price="0.6984"
last_trade_size="4037"
last_trade_time="4:00pm"
low="0.6910"
low_52_weeks="0.5100"
market_capitalization="29.30M"
moving_average_200_day="1.9515"
moving_average_50_day="0.6241"
name="Anthera Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="2.8500"
open="0.7200"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-64.2114%"
percent_change_from_50_day_moving_average="+11.9019%"
percent_change_from_52_week_high="-85.7469%"
percent_change_from_52_week_low="+36.9412%"
previous_close="0.7374"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.0967"
price_per_sales="213.3643"
revenue="144999.00"
shares_outstanding="41955000"
short_ratio="3.7000"
stock_exchange="NGM"
symbol="ANTH"
volume="1370689"
weeks_range_52="0.5100 - 4.9000"
